CHANGES ON BOARD OF DIRECTORS OF ARSEUS
Waregem (Belgium), 25 November 2009 – Arseus announces today that the transactions announced on 9 November 2009 have been completed. As a result, Waterland Private Equity Investments has acquired through its fourth fund 7,500,000 Arseus shares (24.04%) from Omega Pharma NV and 330,000 Arseus shares (1.06%) from Couckinvest NV.
Based on the denominator of 31,195,121 (total number of shares), the shareholding structure after completion of the transaction is as follows:
Number of shares
Percentage of total
Waterland Private Equity Fund IV CV
7,830,000
25.10%
Couckinvest NV/Coucke
3,528,080
11.31%
Fortis Investment Management SA
2,756,357
8.84%
Arseus NV (treasury shares)
973,915
3.12%
Public
16,106,769
51.63%
Benoit Graulich and Rudi De Becker resigned as members of the board of directors of Arseus NV, effective on the date of the closing of the transaction. In order to replace them, the board of directors decided to co-opt WPEF IV Holding Coöperatief WA, permanently represented by Frank Vlayen, and Supplyco BV, permanently represented by Cedric Van Cauwenberghe, as members of the board of directors with effect from 25 November 2009.
A special shareholders’ meeting of Arseus NV will be convened on 22 December 2009. During this shareholders’ meeting it is proposed to ratify the co-optation of WPEF IV Holding Co√∂peratief WA, permanently represented by Frank Vlayen, and Supplyco BV, permanently represented by Cedric Van Cauwenberghe, as members of the board of directors. It is further proposed to appoint Enhold NV, permanently represented by Socius BVBA, represented by Marcel Colla, as a member of the board of directors of Arseus NV. These appointments will be for a term of four years, until the annual shareholders’ meeting of 2013.
Arseus NV wishes to thank Benoit Graulich and Rudi De Becker most sincerely for their commitment, involvement and constructive contributions to the work of the board of directors.
Please open the link below for the full press release: